-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HBV-TCR T Cell Therapy in Hepatitis B
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HBV-TCR T Cell Therapy in Hepatitis B report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HBV-TCR T Cell Therapy in Hepatitis B Drug...
-
Sector Analysis
Corneal Implants Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Corneal Implants Market Report Overview The corneal implants market size was valued at $489.4 million in 2023. The corneal implants market will grow at a CAGR of more than 1% from 2023 to 2033. Increasing cases of corneal blindness and the surging popularity of value-based healthcare have allowed an increased number of corneal donations, thus, driving the corneal implants market growth. Corneal Implants Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights on the Corneal Implants Market...
-
Product Insights
Post-Transplant Lymphoproliferative Disorder – Drugs In Development, 2023
Global Markets Direct’s, ‘Post-Transplant Lymphoproliferative Disorder - Drugs In Development, 2023’, provides an overview of the Post-Transplant Lymphoproliferative Disorder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Post-Transplant Lymphoproliferative Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Lymphoproliferative Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Lymphoproliferative Disorders - Drugs In Development, 2023’, provides an overview of the Lymphoproliferative Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lymphoproliferative Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Lymphocryptovirus Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Lymphocryptovirus Infections - Drugs In Development, 2023’, provides an overview of the Lymphocryptovirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lymphocryptovirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Cytomegalovirus (HHV-5) Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Cytomegalovirus (HHV-5) Infections - Drugs In Development, 2023’, provides an overview of the Cytomegalovirus (HHV-5) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cytomegalovirus (HHV-5) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Nasopharyngeal Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Nasopharyngeal Cancer - Drugs In Development, 2023’, provides an overview of the Nasopharyngeal Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Nasopharyngeal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
South Sumatra 1(Sumsel 1) Power Plant
South Sumatra 1(Sumsel 1) Power Plant is a thermal project located in South Sumatra, Indonesia. The project is owned by China Shenhua Energy Co Ltd; PT Lion Power Energy and is developed by PT Shenhua Guohua Lion Power Indonesia. The project is currently under construction. Empower your strategies with our South Sumatra 1(Sumsel 1) Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered...
-
Product Insights
Mareesburg Project
The Mareesburg Project is a platinum project in South Africa. It is currently at the feasibility stage. Empower your strategies with our Mareesburg Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...